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Chorionic Villus Sampling (CVS) has several advantages over amniocentesis: it may be performed at an earlier gestational age, the 
results are quicker to obtain and there’s a lower miscarriage risk – 1%. However, the higher prevalence of discrepant fetal and villus 
sampling material’s karyotype findings is a disadvantage of this technique – 0.5%. This is caused, amongst other causes, by 
placental mosaicism which consists of two genetically different cell lines. There are three types of placental mosaicism according to 
the abnormal cell line location: Type I – in the cytotrophoblast; Type II – in the villus’ stroma; Type III –  in both the above locations.  
We present a case report about a 36-year-old pregnant woman going through our Department’s 1st trimester combined 
screening program; a CVS was performed, which showed Confined Placental Mosaicism (CPM). 
Although the pregnant woman was in the low-risk group for 
aneuploidy, the patient wanted the cytogenetic study to be 
performed in order to reduce maternal anxiety. CVS was 
performed at the gestational age of 12 weeks + 5 days and the 
karyotype was 47XY+2/46XY. For the correct interpretation of this 
data an amniocentesis was performed at the gestational age of 
15 weeks + 6 days, which showed a 46XY karyotype. We 
therefore conclude that the cytogenetic analysis of the CVS was 
the result of a CPM. A careful follow-up including fetal 
echocardiogram and seriated ultrasonographic monitoring was 
used to safely exclude malformations and fetal growth restriction. 
We verified no occurences throughout pregnancy, delivery and 
perinatal period. 
CVS practice was recently implemented in our country and 
has many advantages over amniocentesis. Besides the fact 
that an earlier gestational age usually means less affective 
bonding to the fetus and therefore makes medical 
termination of pregnancy somewhat less difficult, one should 
consider specific situations like the one reported in which 
CPM may be diagnosed. This condition is associated with 
increased risk of fetal growth restriction, so the clinician 
should be aware of the need for a more careful follow-up, 
since perinatal complications, which should be anticipated 
and treated, can be expected in 16-21% of these cases. 
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